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PreviewsA T cell subset referred to as Th22 cell
has been described mainly in humans
(Duhen et al., 2009; Volpe et al., 2009),
and the existence of Th22 cells in mice
has been controversial. Human CD4+
Th22 cells have been detected in inflamed
and diseased skin in vivo and can be
induced from naive T cells after T cell
receptor stimulation in the presence
of IL-6 and TNF in vitro. Furthermore,
IL-22 expression by human CD4+ T cells
correlates better with expression of
the Th1 cell subset markers IFN-g and
T-bet than with expression of the Th17
cell subset marker IL-17A (Duhen et al.,
2009; Volpe et al., 2009). Th22 cells
described by Basu et al. (2012) have
similar characteristics to human Th22
cells and fit the criteria to be Th22 cells.
However, it is still unclear whether or not
Th17 and Th22 cell subsets, particularly
observed in pathogen-infected mice, are
truly distinct or represent activation
stages of a single plastic lineage modu-
lated by environmental cues. To define
Th22 cells as a unique population distinct
from Th17 cells, identification of a mole-
cule(s) that acts as a master regulator of954 Immunity 37, December 14, 2012 ª2012Th22 cell development and function, in
addition to T-bet and AhR, or a more
detailed cellular characterization will be
required. Another question this study
raises is the functional specificity of
Th22 cells, in other words, the qualitative
difference among Th22 cells, IL-22+
ILC3s, and Th17 cells. It has been re-
ported that IL-22+ ILC3s expand until
day 6 of C. rodentium infection but that
their number declines thereafter (Sonnen-
berg et al., 2011); therefore, activated
IL-22+ ILC3s may persist for a shorter
period compared to activated Th22
cells. This difference in turnover may be
a reason why adaptive Th22 cells are
required for clearance of this pathogen.
Further studies are required to completely
reveal the specific functions of Th22
cells during health and disease.
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Lymph nodes are compartmentalized organs but whether this feature has a role in T cell differentiation has
been unclear. In this issue, Groom et al. (2012) reveal that spatially separated expression of two CXCR3
ligands guides Th1 cell development.Generation of correctly polarized CD4+
T cell subsets is critical for successful
immune responses. Yet the complete set
of requirements for induction of effector
T cells within responding lymph nodes
(LNs) is not known. Subset-specific che-
mokine receptors have well-established
roles in guiding effector T cells to periph-eral tissues, but whether these receptors
influence early T cell differentiation events
has been less clear. In this issue, Groom
et al. (2012) show that the T helper 1
(Th1) cell-associated chemokine receptor
CXCR3 plays a crucial role in promoting
cell-cell interactions and guiding intra-
lymph node movements of activatedT cells that favor differentiation toward
an interferon-g (IFN-g)-producing Th1
cell phenotype (Groom et al., 2012). This
movement depends on expression of
two CXCR3 ligands in distinct LN
compartments.
CXCR3 has three ligands: CXCL9,
CXCL10, and CXCL11. Their original
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Previewsmonikers hint at the Th1 cell connection of
this chemokine subfamily: CXCL9 was
known as monokine induced by IFN-g
(MIG), CXCL10 as interferon inducible
protein 10 (IP10), and CXCL11 as inter-
feron-inducible T cell alpha chemoattrac-
tant (I-TAC). CXCR3 facilitates recruit-
ment of effector T cells to numerous
inflammatory sites, such as the influ-
enza-infected lung, the toxoplasma-
infected brain, and organ allografts where
CXCL9 and CXCL10 have been found
strongly induced (see reviews cited in
Groom et al., 2012). The role of CXCL11
has been less well studied, in part
because B6 mice lack a functional
CXCL11 gene. Despite the emphasis on
CXCR3 ligands as inflammatory chemo-
kines, CXCR3 is induced very rapidly on
T cells after activation. This observation
in conjunction with work demonstrating
the presence of CXCR3 ligands in
lymphoid organs suggested a role for
CXCR3 during priming events that could
affect T cell differentiation. Several recent
studies have shown that expression of
CXCR3 on CD8+ T cells can influence
the balance between generation of termi-
nally differentiated effector and long-lived
memory cells as well as the functional
quality of the latter (Hu et al., 2011; Kohl-
meier et al., 2011; Kurachi et al., 2011).
However, this effect of CXCR3 seems to
be mediated through promoting further
exposure of CD8+ T cells to antigen
and inflammatory mediators either in
lymphoid or peripheral tissues at later
stages rather than by influencing early
activation events.
To test whether CXCR3 had a cell-
intrinsic role during CD4+ T cell priming,
Groom et al. (2012) first made use of an
ovalbumin (OVA)-loaded and lipopolysac-
charide (LPS) plus polyinosinic-polycyti-
dylic acid (poly(I:C))-exposed dendritic
cell (DC) immunization strategy. In addi-
tion to being a potent means of inducing
effector T cell differentiation, this strategy
had the advantage of allowing manipula-
tion of chemokine production by the
antigen-presenting cells. CXCR3 induc-
tion began occurring on the activated
T cells by 24 hr after DC injection and
was maximal by 36 hr. The investigators
then asked how CXCR3 deficiency in the
T cells affected their activation and differ-
entiation. Early T cell proliferation was
found to occur independently of the
receptor. However, T cells requiredCXCR3 for maximal induction of IFN-g at
3 days after antigen exposure, but not
tumor necrosis factor (TNF) or inter-
leukin-2 (IL-2). Whether the CXCR3-defi-
cient T cells had become skewed toward
other cytokine-producing Th cell subsets
was not investigated. The activated
DCs expressed considerable amounts of
CXCR3 ligands, suggesting that they
might play a role in further recruitment
of activated T cells. Indeed, real-time
imaging of lymph nodes showed that
fewer of the CXCR3-deficient than wild-
type antigen-specific T cellswere in stable
contact with the transferred DCs, pointing
to the possibility that contact duration
might be one mechanism by which
CXCR3 signaling reinforces Th1 cell fate.
Although many of the DCs expressed
high amounts of both CXCL9 and
CXCL10, a defect in Th1 cell induction
was seen only when Cxcl10/ but not
Cxcl9/ DCs were used. Whether this re-
flected a unique ability of CXCL10 to
promote DC-T cell conjugates, insufficient
production of CXCL9 protein, or a role
for CXCL10 single-positive rather than
CXCL9 and CXCL10 double-positive DCs
in priming Th1 cell responses remains an
area for future investigation. Interestingly,
when CXCL10-deficient DCs were used,
the Th1 cell defect was greater than
observed in the adoptive Cxcr3/ T cell
transfer system, suggesting that DC-
derived CXCL10 recruits other cells that
contribute to promoting Th1 cell differenti-
ation. A candidate here is IFN-g-produc-
ing NK cells because previous work
has shown that DC immunization leads to
their recruitment in a CXCR3-dependent
manner and contributes to Th1 cell induc-
tion (Martı´n-Fontecha et al., 2004).
Contrasting with the DC transfer model,
in a more conventional antigen-plus-
adjuvant immunization system, both
CXCL9- and CXCL10-deficient mice
showed a reduction in the IFN-g-pro-
ducing CD4+ T cell response (Groom
et al., 2012). This nonredundant require-
ment for both chemokines raised new
questions about how CXCL9 and
CXCL10 were functioning. Bone marrow
(BM) chimera experiments showed that
CXCL10 was important in hematopoietic
cells, presumably including DCs but prob-
ably also macrophages, whereas CXCL9
was needed in radiation-resistant stromal
cells, suggesting that it was not acting in
the same way as CXCL10.Immunity 37, DTo determine whether CXCL9 and
CXCL10 might help organize distinct LN
niches, the investigators took the elegant
approach of generating a bacterial artifi-
cial chromosome (BAC) transgenic
reporter mouse line, REX, that ‘‘paints’’
CXCL9-producing cells red (with RFP)
and CXCL10-producing cells blue (with
BFP) (Groom et al., 2012). By using REX
mice, they discovered that immunization
with an antigen-LPS-poly(I:C) cocktail
led to induction of CXCL10 in interfollicu-
lar regions within 12 hr but only small
amounts of CXCL9 in these regions. At
36 hr, CXCL10 was seen throughout
medullary, interfollicular, and subcapsular
sinus regions; CXCL9 was now strongly
induced in interfollicular regions and in
some T zone areas but minimally in the
medulla. When T cell distribution was
examined at 24–36 hr, wild-type T cells
were enriched in interfollicular and
medulla regions whereas Cxcr3/
T cells remained in the T cell zone. In
Cxcl10/ hosts, wild-type T cells re-
mained in the T cell zone but showed
some migration toward interfollicular
areas, the site of highest CXCL9 expres-
sion (Figure 1). In Cxcl9/ hosts, wild-
type T cells again remained in the T cell
zone but showed some migration toward
the medulla, a site of high CXCL10
expression (Groom et al., 2012).
Differential induction of CXCL10 and
CXCL9 by type I IFN and IFN-g has been
well established and most probably forms
the basis for the observed sequential
expression of these two chemokines in
the immunized LN by both myeloid and
stromal cells (Groom et al., 2012). Recent
work by Sung et al. (2012) shows that
CXCL10 is induced rapidly in a type I
IFN-dependent manner after lymphocytic
choriomeningitis virus (LCMV) infection
whereas CXCL9 induction occurs later
and is dependent on IFN-g and the pres-
ence of central memory T cells. Thus,
the early CXCL10 expression observed
by Groom et al. (2012) is probably
secondary to type I IFN induced by LPS
and poly(I:C) and it led to recruitment of
T cells to DCs. After T cell activation, the
initial phase of IFN-g production led to
CXCL9 expression in the stromal com-
partment. Together these chemokines
amplified or reinforced the circuit leading
to Th1 cell priming but at different LN
regions (Figure 1). The observation that
the stromal compartment was the majorecember 14, 2012 ª2012 Elsevier Inc. 955
Figure 1. Expression of CXCR3 Ligands within Distinct LN Compartments Drives Optimal
Th1 Cell-Associated IFN-g Production
Left panel is a simplified depiction of relocalization of antigen-specific T cells after activation in relation to
LN compartments that express CXCL9 or CXCL10. T cells become fully activated and express highest
amounts of IFN-g only if both CXCL9 and CXCL10 are present. Right panel shows temporal and spatial
expression of CXCR3 ligands in response to immunization. (1) Afferent lymphatics bring in activated
DC-bearing antigen, or soluble antigen, TLR ligands, and type I IFN from infected tissue. (2) Whereas
innate stimuli induce expression of CXCL10 in mostly hematopoietic cells in the medullary region, DCs
activate antigen-specific T cells in the T zone. (3) Activated T cells upregulate CXCR3 expression, which
promotes frequent and prolonged encounters with CXCL10-expressing antigen-presenting cells (APCs)
either in the T zone or themedullary region. (4) IFN-g produced by activated T cells induces CXCL9 expres-
sion by unidentified stromal cells in the interfollicular region. (5) CXCL9may attract other CXCR3-express-
ing cells, such as NK cells, as well as activated antigen-specific CD4 T cells to the interfollicular areas,
leading to more exposure to IFN-g and other cytokines resulting in optimal Th1 cell differentiation.
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Previewssource of CXCL9might explain why trans-
fer of CXCL9-deficient DCs into wild-type
mice did not have an impact on T cell
IFN-g production.
Whether the contribution of stromal
CXCL9 to Th1 cell induction is all through
effects on activated T cell positioning or
through effects on NK cell (Martı´n-Fonte-
cha et al., 2004) or monocyte (Janatpour
et al., 2001) recruitment remains to be fully
addressed. More precise identification of
the CXCL9-producing stromal cells and
their cytokine production profile should
further this endeavor. Because IFN-g is
undoubtedly the single most important
cytokine in reinforcing a Th1 cell-associ-
ated program (Mullen et al., 2001), the
CXCL9+ stromal cells, which probably956 Immunity 37, December 14, 2012 ª2012include gp38+ fibroblastic reticular cells
(Sung et al., 2012), may provide a niche
to concentrate the newly activated Th1
cells with other IFN-g producing cells,
such as NK cells and gdT cells (Kasten-
mu¨ller et al., 2012), thus increasing Th1
cell exposure to this cytokine. Why this
may occur in the interfollicular but not
the medullary areas of the LN could be
due to lack of access of some cell types
to the latter region. Such a model may
explain why both CXCR3 ligands are
necessary for optimal Th1 cell-associated
IFN-g production.
Is this type of chemokine-guided
effector differentiation unique to Th1
cells? Probably not, as indicated by a
recent study that provided evidence forElsevier Inc.CXCR5-directed positioning of cells in in-
terfollicular regions duringTh2 cell priming
in response to a nematode, broadening
the earlier finding that CXCR5 contributes
to follicular helper T cell differentiation
(Leo´n et al., 2012). Politics aside, clearly
much more work is needed, with colorful
reporters and temporal analyses like
those of Groom et al. (2012), if we are
to assemble a complete cellular and
molecular picture of the lymphoid niches
supporting effector T cell priming.REFERENCES
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